BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10891446)

  • 21. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa.
    Losonczy G; Rosenberg N; Kiss C; Kappelmayer J; Vereb G; Kerényi A; Balogh I; Muszbek L
    Thromb Haemost; 2005 May; 93(5):904-9. PubMed ID: 15886807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
    Chen YP; O'Toole TE; Ylänne J; Rosa JP; Ginsberg MH
    Blood; 1994 Sep; 84(6):1857-65. PubMed ID: 8080992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
    Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
    Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation.
    Rosenberg N; Landau M; Luboshitz J; Rechavi G; Seligsohn U
    J Thromb Haemost; 2004 Jul; 2(7):1167-75. PubMed ID: 15219201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of alpha IIb: demonstration of the importance of calcium-binding domains in the conformation of alpha IIb beta 3.
    Basani RB; Vilaire G; Shattil SJ; Kolodziej MA; Bennett JS; Poncz M
    Blood; 1996 Jul; 88(1):167-73. PubMed ID: 8704171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
    Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL
    Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation.
    Induruwa I; Moroi M; Bonna A; Malcor JD; Howes JM; Warburton EA; Farndale RW; Jung SM
    J Thromb Haemost; 2018 Feb; 16(2):389-404. PubMed ID: 29210180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.
    Wilcox DA; Paddock CM; Lyman S; Gill JC; Newman PJ
    J Clin Invest; 1995 Apr; 95(4):1553-60. PubMed ID: 7706461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
    Hauschner H; Mor-Cohen R; Seligsohn U; Rosenberg N
    J Thromb Haemost; 2012 Feb; 10(2):289-97. PubMed ID: 22136613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome.
    Peyruchaud O; Nurden AT; Milet S; Macchi L; Pannochia A; Bray PF; Kieffer N; Bourre F
    Blood; 1998 Dec; 92(11):4178-87. PubMed ID: 9834222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
    Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
    Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a talin-binding site in the integrin beta(3) subunit distinct from the NPLY regulatory motif of post-ligand binding functions. The talin n-terminal head domain interacts with the membrane-proximal region of the beta(3) cytoplasmic tail.
    Patil S; Jedsadayanmata A; Wencel-Drake JD; Wang W; Knezevic I; Lam SC
    J Biol Chem; 1999 Oct; 274(40):28575-83. PubMed ID: 10497223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of alpha IIb subunit integrin.
    Westrup D; Santoso S; Follert-Hagendorff K; Bassus S; Just M; Jablonka B; Kirchmaier CM
    Thromb Haemost; 2004 Nov; 92(5):1040-51. PubMed ID: 15543332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
    Phillips DR; Nannizzi-Alaimo L; Prasad KS
    Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.
    Holmbäck K; Danton MJ; Suh TT; Daugherty CC; Degen JL
    EMBO J; 1996 Nov; 15(21):5760-71. PubMed ID: 8918453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide.
    Derrick JM; Shattil SJ; Poncz M; Gruppo RA; Gartner TK
    Thromb Haemost; 2001 Sep; 86(3):894-901. PubMed ID: 11583324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.